MECOM and neoplasm: Our clinical relevance analysis clearly revealed that a better survival in patient with PDAC was associated with high levels of PRDM3 expression, but not with age, gender, tumor size, location, TNM (tumor-node-metastasis), or CA19-9 (Table 1).